JP2000044474A - Water-soluble vitamin composition - Google Patents

Water-soluble vitamin composition

Info

Publication number
JP2000044474A
JP2000044474A JP22534398A JP22534398A JP2000044474A JP 2000044474 A JP2000044474 A JP 2000044474A JP 22534398 A JP22534398 A JP 22534398A JP 22534398 A JP22534398 A JP 22534398A JP 2000044474 A JP2000044474 A JP 2000044474A
Authority
JP
Japan
Prior art keywords
water
soluble vitamin
composition
vitamin
fatty acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP22534398A
Other languages
Japanese (ja)
Other versions
JP4173927B2 (en
Inventor
Hironobu Nanbu
宏暢 南部
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiyo Kagaku KK
Original Assignee
Taiyo Kagaku KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiyo Kagaku KK filed Critical Taiyo Kagaku KK
Priority to JP22534398A priority Critical patent/JP4173927B2/en
Publication of JP2000044474A publication Critical patent/JP2000044474A/en
Application granted granted Critical
Publication of JP4173927B2 publication Critical patent/JP4173927B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To obtain a water-soluble vitamin composition useful for foods, pharmaceuticals and cosmetics, capable of stably preserving a water-soluble vitamin therein for a long time and superior in taste by including the water-soluble vitamin, a glycerin fatty acid ester and a neutral lipid. SOLUTION: This composition is obtained by including (A) a water-soluble vitamin (e.g. L-ascorbic acid) in the form of solid particles with an average diameter of pref. <=1 μm, (B) a glycerin fatty acid ester (e.g. polyglycerin condensed ricinoleic acid ester) pref. <=4 in HLB number and (C) a neutral lipid (e.g. medium chain fatty acid triglyceride)(with a melting point of pref. <=45 deg.C in the ratios of A to the whole composition of pref. 15 to 50 wt.% and of B/C of 1 to 100 wt.%. The composition, when dispersed in an aqueous food of e.g. palatable beverage or processed milk product or in an aqueous cosmetic of e.g. cosmetic emulsion, forms a stable W/O/W emulsion system without eluting the water-soluble vitamin contained therein through an emulsification inversion.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、水溶性ビタミン類
及びその誘導体を生理活性成分として含有する組成物、
及び該組成物を用いた食品、医薬品、化粧品に関するも
のである。
The present invention relates to a composition containing a water-soluble vitamin and a derivative thereof as a physiologically active ingredient,
And foods, medicines and cosmetics using the composition.

【0002】[0002]

【従来の技術】水溶性ビタミン類及びその誘導体はその
生理作用により医薬品や化粧品、食品の栄養強化、また
は酸化防止剤として広範な用途に供されている。しかし
ながら、これらの化合物は特異な味を有するため、食品
用途での利用に制限を受ける事やL−アスコルビン酸に
代表される様に酸化、熱、光に対して不安定という欠点
がある。
2. Description of the Related Art Water-soluble vitamins and derivatives thereof have been used in a wide range of applications as nutrients for pharmaceuticals, cosmetics and foods or as antioxidants due to their physiological actions. However, since these compounds have a unique taste, they are disadvantageous in that they are restricted in use in food applications and are unstable to oxidation, heat, and light as represented by L-ascorbic acid.

【0003】水溶性ビタミンの安定化法としては、脂肪
酸とのエステル化(特公昭55−45546等)やリン
酸エステル化及び錯塩化(特開平7−53581等)と
いったビタミン分子の一部の官能基を適当な置換基で置
き換える方法、またはアミノ酸や有機酸を安定化剤とし
て併用する方法(特公昭57−48050)等が提案さ
れているが、これらの誘導体はビタミンの薬理効果の低
下や副作用の発現等の問題点が残る。
As a method for stabilizing a water-soluble vitamin, there are some functionalities of vitamin molecules such as esterification with a fatty acid (Japanese Patent Publication No. 55-45546, etc.), phosphoric esterification and complexation (Japanese Patent Laid-Open No. 7-53581, etc.). A method has been proposed in which a group is replaced with an appropriate substituent, or a method in which an amino acid or an organic acid is used in combination as a stabilizer (Japanese Patent Publication No. 57-48050). Problems remain.

【0004】アミノ酸や有機酸を安定化剤として併用す
る場合においては、水溶性ビタミン自体の酸化やpH条
件によってアンモニア等が発生したり、安定化剤自体の
呈味性が使用上好ましくない影響を及ぼす等の問題があ
る。
When an amino acid or an organic acid is used in combination as a stabilizer, the oxidation of water-soluble vitamin itself or the pH conditions may cause ammonia or the like, or the taste of the stabilizer itself may have an adverse effect on use. There are problems such as the effect.

【0005】その他、ビタミン及びその塩類単体を融点
50〜80℃の油脂と乳化剤との混合物に混合して被覆
する方法(特公昭57−48050)やビタミン及びそ
の塩類の水溶液を親油性のソルビタン脂肪酸エステル、
ショ糖脂肪酸エステル及びポリグリセリン縮合リシノレ
イン酸エステル等を添加した油脂中に乳化させて油中水
滴型(W/O)乳化油脂組成物とする方法(特公昭63
−96727,特開平6−343400等)等が提案さ
れている。
[0005] In addition, a method of mixing and coating a simple substance of a vitamin and a salt thereof with a mixture of an oil and a fat having a melting point of 50 to 80 ° C and an emulsifier (Japanese Patent Publication No. 57-48050), or a method of preparing an aqueous solution of a vitamin and a salt thereof from a lipophilic sorbitan fatty acid ester,
A method of emulsifying fats and oils to which a sucrose fatty acid ester and a polyglycerin condensed ricinoleate ester and the like are added to obtain a water-in-oil (W / O) emulsified fat and oil composition (Japanese Patent Publication No. Sho 63)
-96727, JP-A-6-343400, etc.).

【0006】しかしながら前者では、水溶性ビタミン類
の結晶表面を高融点の固体油脂で被覆してW/O分散型
の固体/固体界面を形成させる方法であり、ビタミン類
の安定性には優れるものの、使用するビタミン結晶が数
十μm以上の粗大結晶であり、高融点の固体油脂で被覆
された0.2〜2mm程度の粒状形態であるためにその
応用範囲が限定され、特に液状製品への応用は極めて難
しくなる。
However, in the former method, a W / O dispersed solid / solid interface is formed by coating the crystal surface of a water-soluble vitamin with a solid oil having a high melting point. The application range is limited because the vitamin crystals used are coarse crystals of several tens of μm or more, and are in a granular form of about 0.2 to 2 mm coated with a high melting point solid fat, especially for liquid products. Application becomes extremely difficult.

【0007】後者においては、内部水相が0.2〜5μ
m程度のW/O乳化組成物が得られ、応用範囲は広がる
もののビタミン類が水溶液状態であるために乳化界面の
物理的強度が弱く、殺菌等の加熱工程を経ると分解等が
生じ易くなり、且つW/O乳化型の液体/液体界面であ
る事から攪拌やポンプ輸送等の物理的応力にさらされる
と乳化状態が転相破壊し易い欠点がある。
In the latter, the internal aqueous phase is 0.2 to 5 μm.
m / W emulsified composition of about m is obtained, and the range of application is widened, but the physical strength of the emulsified interface is weak because vitamins are in an aqueous solution state, and decomposition and the like are likely to occur after a heating step such as sterilization. In addition, since it is a W / O emulsified liquid / liquid interface, there is a disadvantage that the emulsified state is liable to undergo phase inversion destruction when exposed to physical stress such as stirring or pumping.

【0008】[0008]

【発明が解決しようとする課題】本発明の目的は、水溶
性ビタミンを長期間安定に保ち、且つ呈味性に優れた水
溶性ビタミン組成物を提供する事にある。
SUMMARY OF THE INVENTION It is an object of the present invention to provide a water-soluble vitamin composition which keeps the water-soluble vitamin stable for a long period of time and which is excellent in taste.

【0009】[0009]

【課題を解決するための手段】本発明者らは、前期の目
的を達成するために鋭意検討を行った結果、水溶性ビタ
ミン、グリセリン脂肪酸エステル及び中性脂質を含有す
る水溶性ビタミン組成物が、水溶性ビタミン特有の異味
をマスキングでき、且つ安定性に優れる事を見出し、本
発明を完成するに至った。
Means for Solving the Problems The inventors of the present invention have conducted intensive studies to achieve the object of the first period, and as a result, have found that a water-soluble vitamin composition containing a water-soluble vitamin, a glycerin fatty acid ester and a neutral lipid can be obtained. The present inventors have found that it is possible to mask a peculiar taste peculiar to a water-soluble vitamin and to have excellent stability, and have completed the present invention.

【0010】即ち本発明は、物理的破砕によって平均粒
径1μm以下に超微粒子化した水溶性ビタミンをHLB
4以下のグリセリン脂肪酸エステル及び融点が45℃以
下の中性脂質中にW/O分散させたビタミン組成物に関
する。
That is, the present invention relates to a method for converting water-soluble vitamins, which have been ultrafinely divided into particles having an average particle diameter of 1 μm or less by physical crushing, into HLB.
The present invention relates to a vitamin composition dispersed in W / O in a neutral lipid having a glycerin fatty acid ester of 4 or less and a melting point of 45 ° C. or less.

【0011】[0011]

【発明の実施の形態】本発明における水溶性ビタミンは
特に限定するものではないが、ビタミンC及びその誘導
体であるアスコルビン酸−2−リン酸エステルやアスコ
ルビン酸−2−グルコシド類,ビタミンB1 及びその誘
導体であるチアミンプロピルジスルフィド、チアミンテ
トラフルフリルジスルフィド、チアミン−8−メチル−
6−アセチルジヒドロチオクテートジスルフィド、O,
S−ジカルボエトキシチアミン塩酸塩、S−ベンゾイル
チアミン−O−モノフォスフェート、O−ベンゾイルチ
アミンジスルフィド,ビタミンB2 及びその誘導体であ
る5−デアザ−7,8−ジデメチル−8−ヒドロキシリ
ボフラビン等やフラビンモノヌクレオチド、フラビンア
デニンジヌクレオチド等の補酵素型リボフラビン,ピリ
ドキシン、ピリドキサール、ピリドキサミン等の遊離型
ビタミンB6 及びそのリン酸エステル型又はグルコシド
型誘導体,ビタミンB12,ナイアシン,パントテン酸及
び葉酸、から選ばれる1種又は2種以上の混合物である
が、好ましくは中性脂質に不溶で且つ物理的破砕によっ
てレーザー回折型粒度分布測定による平均粒径が1μm
以下の超微粒子化する事ができる性質の水溶性ビタミン
である。物理的破砕方法に関しては、コボールミル等の
湿式摩砕機やジェットミル等の乾式破砕機、又は液体窒
素を利用する凍結粉砕等の使用が挙げられるが、レーザ
ー回折型粒度分布測定により平均粒径1μm以下の超微
粒子化ができる性能のものであれば何れを使用しても差
し支えない。平均粒径が1μmより大きくなると中性脂
質中での分散安定性が低下し、ビタミンの微粒子が沈殿
分離する。
BEST MODE FOR CARRYING OUT THE INVENTION The water-soluble vitamin in the present invention is not particularly limited, but vitamin C and its derivatives ascorbic acid-2-phosphate, ascorbic acid-2-glucosides, vitamin B 1 and Derivatives such as thiamine propyl disulfide, thiamine tetrafurfuryl disulfide, thiamine-8-methyl-
6-acetyldihydrothioctoate disulfide, O,
S- dicarboethoxy thiamine hydrochloride, S- benzoyl thiamine -O- monophosphate, O- benzoyl thiamine disulfide, is vitamin B 2 and its derivatives 5-deaza-7,8 Jidemechiru -8-hydroxy riboflavin like Ya flavin mononucleotide, coenzyme riboflavin such as flavin adenine dinucleotide, pyridoxine, pyridoxal, free-form vitamin of B 6 and its phosphoric acid ester type or a glucoside type derivatives such as pyridoxamine, vitamin B 12, niacin, pantothenic acid and folic acid, the It is a selected one or a mixture of two or more, but is preferably insoluble in neutral lipids and has an average particle size of 1 μm as measured by laser diffraction particle size distribution by physical crushing.
It is a water-soluble vitamin with the following properties that can be converted to ultrafine particles. Regarding the physical crushing method, use of a wet crusher such as a co-ball mill, a dry crusher such as a jet mill, or freeze crushing using liquid nitrogen, etc. is mentioned, but the average particle size is 1 μm or less by laser diffraction type particle size distribution measurement. Any material can be used as long as it has a performance capable of forming ultrafine particles. If the average particle size is larger than 1 μm, the dispersion stability in neutral lipids will be reduced, and fine particles of vitamins will precipitate and separate.

【0012】本発明の水溶性ビタミンの含有量は特に限
定するものではないが、該組成物中1〜70重量%であ
る事が好ましく、更に好ましくは15〜50重量%であ
る。ビタミン量が1重量%より少ない場合は、主剤であ
るビタミン量が微量となりビタミン組成物としての用を
成さない。また、ビタミン量が70重量%より多い場合
には、構造粘度が極度に高まり流動性を失ってしまう為
に後の加工特性及び応用範囲を著しく狭める事となる。
Although the content of the water-soluble vitamin of the present invention is not particularly limited, it is preferably from 1 to 70% by weight, more preferably from 15 to 50% by weight in the composition. When the amount of vitamin is less than 1% by weight, the amount of vitamin as a main ingredient becomes very small, so that it is not used as a vitamin composition. On the other hand, if the amount of vitamin is more than 70% by weight, the structural viscosity becomes extremely high and the fluidity is lost, so that the subsequent processing characteristics and application range are significantly narrowed.

【0013】本発明に用いるグリセリン脂肪酸エステル
は特に限定するものではないが、HLB4以下の有機酸
モノグリセリド,ポリグリセリン脂肪酸エステル及びポ
リグリセリン縮合リシノレイン酸エステル、好ましくは
クエン酸グリセリド、リンゴ酸グリセリド、酢酸グリセ
リド、コハク酸グリセリド、ジアセチル酒石酸グリセリ
ド、平均重合度2〜10のポリグリセリンと炭素数6〜
22の脂肪酸エステル及び平均重合度2〜10のポリグ
リセリンと縮合度2〜4のポリリシノレイン酸のエステ
ルから選ばれる1種または2種以上の混合物であり、グ
リセリン脂肪酸エステルは中性脂質に対して1〜100
重量%配合するが、添加量が1重量%未満の場合はビタ
ミン微粒子結晶を十分に分散させる事が不可能であり、
100重量%より多い場合には該組成物を改めて水系に
分散させる際、乳化転相により内包する水溶性ビタミン
微粒子の溶出が生じ易くなり、安定なW/O/W乳化系
を構成するに支障を来たす。
The glycerin fatty acid ester used in the present invention is not particularly limited. However, organic acid monoglyceride having an HLB of 4 or less, polyglycerin fatty acid ester and polyglycerin condensed ricinoleate, preferably citrate glyceride, malate glyceride, glyceride acetate Succinic acid glyceride, diacetyltartaric acid glyceride, polyglycerol having an average degree of polymerization of 2 to 10 and carbon number of 6 to 6
A mixture of at least one fatty acid ester of 22 and an ester of polyglycerol having an average degree of polymerization of 2 to 10 and polyricinoleic acid having a degree of condensation of 2 to 4; 1-100
However, if the amount added is less than 1% by weight, it is impossible to sufficiently disperse the vitamin microparticle crystals,
When the content is more than 100% by weight, when the composition is newly dispersed in an aqueous system, the included water-soluble vitamin fine particles are easily eluted due to emulsification phase inversion, which hinders the formation of a stable W / O / W emulsion system. Come.

【0014】本発明に用いる中性脂質は特に限定するも
のではないが、中鎖脂肪酸トリグリセリド等の合成油脂
や大豆、米、菜種、カカオ、椰子等の油糧種子から得ら
れる一般的な植物性油脂及び牛脂、乳脂、豚脂等の動物
性油脂の何れでも使用でき、これらに本来含まれている
リン脂質、ステロール類、ワックス類及び油溶性ビタミ
ン類等が共存しても一向に差し支えないが、融点が45
℃以下の加温域で使用できる油成分が好ましく、更に好
ましくは融点が常温以下である。融点が45℃より高い
中性脂質を用いると水溶性ビタミン組成物の調製及び食
品等への添加時に複数の加熱工程が必要となる為、強度
の熱履歴を水溶性ビタミンに与える事となり、応用範囲
も極めて狭められる事となる。以下に実施例及び試験例
によって本発明を説明するが、その内容に制限されるも
のではない。
The neutral lipid used in the present invention is not particularly limited, but is generally a vegetable oil obtained from synthetic oils such as medium-chain fatty acid triglyceride and oil seeds such as soybean, rice, rapeseed, cacao, and coconut. Fats and beef tallow, milk fat, animal fats such as lard, can be used, and phospholipids, sterols, waxes and oil-soluble vitamins originally contained in them can be used together, Melting point 45
An oil component that can be used in a heating range of not higher than 0 ° C. is preferable, and the melting point is more preferably not higher than room temperature. When a neutral lipid having a melting point higher than 45 ° C. is used, a plurality of heating steps are required at the time of preparing a water-soluble vitamin composition and adding it to foods, etc., so that a strong heat history is given to the water-soluble vitamin. The range will also be extremely narrowed. Hereinafter, the present invention will be described with reference to Examples and Test Examples, but the present invention is not limited thereto.

【0015】[0015]

【実施例】実施例1 中鎖脂肪酸トリグリセリド50重量部(融点−11℃,
太陽化学株式会社製)、ポリグリセリン縮合リシノレイ
ン酸エステル10重量部(サンソフト818H;HLB
1,太陽化学株式会社製)を混合し、L−アスコルビン
酸結晶40重量部(平均粒子径約100μm、日本ロシ
ュ株式会社製)を加えた油性懸濁液を調製し、これをコ
ボールミル(神鋼パンテック株式会社製)に掛け、レー
ザー回折型粒度分布測定によりL−アスコルビン酸の平
均粒子径が0.4μmとなったW/O分散組成物を得
た。
Example 1 50 parts by weight of medium-chain fatty acid triglyceride (melting point -11 ° C,
Taiyo Chemical Co., Ltd.), 10 parts by weight of polyglycerin condensed ricinoleate (Sunsoft 818H; HLB)
1, manufactured by Taiyo Kagaku Co., Ltd.) to prepare an oily suspension containing 40 parts by weight of L-ascorbic acid crystals (average particle size: about 100 μm, manufactured by Nippon Roche Co., Ltd.). And the average particle size of L-ascorbic acid was 0.4 μm as determined by laser diffraction particle size distribution measurement to obtain a W / O dispersion composition.

【0016】実施例2 菜種白絞油70重量部(融点12℃)、ポリグリセリン
縮合リシノレイン酸エステル5重量部(サンソフト81
8H;HLB1,太陽化学株式会社製)及びポリグリセ
リンステアリン酸エステル5重量部(サンファットPS
−68;HLB3.5,太陽化学株式会社製)を混合
し、リボフラビン結晶20重量部(平均粒子径約100
μm、武田薬品工業株式会社製)を加えた油性懸濁液を
調製し、これをコボールミル(神鋼パンテック株式会社
製)に掛け、レーザー回折型粒度分布測定によりリボフ
ラビン結晶の平均粒子径が0.35μmとなったW/O
分散組成物を得た。
Example 2 Rapeseed white squeezed oil 70 parts by weight (melting point 12 ° C.), polyglycerin condensed ricinoleate 5 parts by weight (Sunsoft 81)
8H; HLB1, manufactured by Taiyo Chemical Co., Ltd.) and 5 parts by weight of polyglycerin stearate (Sun Fat PS)
-68; HLB3.5, manufactured by Taiyo Kagaku Co., Ltd.), and mixed with 20 parts by weight of riboflavin crystals (average particle size of about 100).
μm, manufactured by Takeda Pharmaceutical Co., Ltd.) was prepared, and the suspension was applied to a Koball Mill (manufactured by Shinko Pantec Co., Ltd.), and the average particle size of the riboflavin crystals was determined to be 0. W / O became 35 μm
A dispersion composition was obtained.

【0017】実施例3 中鎖脂肪酸トリグリセリド50重量部(融点−11℃,
太陽化学株式会社製)、ポリグリセリン縮合リシノレイ
ン酸エステル5重量部(サンソフト818SX;HLB
0.5,太陽化学株式会社製)、クエン酸モノグリセリ
ド5重量部(サンソフト623M;HLB4,太陽化学
株式会社製)を混合し、L−アスコルビン酸結晶40重
量部(平均粒子径約100μm、日本ロシュ株式会社
製)を加えた油性懸濁液を調製し、これをコボールミル
(神鋼パンテック株式会社製)に掛け、レーザー回折型
粒度分布測定によりL−アスコルビン酸の平均粒子径が
0.4μmとなったW/O分散組成物を得た。
Example 3 50 parts by weight of medium-chain fatty acid triglyceride (melting point -11 ° C.,
Taiyo Chemical Co., Ltd.), 5 parts by weight of polyglycerin condensed ricinoleate (Sunsoft 818SX; HLB)
0.5, manufactured by Taiyo Kagaku Co., Ltd.) and 5 parts by weight of citrate monoglyceride (Sunsoft 623M; HLB4, manufactured by Taiyo Kagaku Co., Ltd.), and 40 parts by weight of L-ascorbic acid crystals (average particle diameter: about 100 μm, Japan An oily suspension to which L-ascorbic acid was added was prepared using a Koball Mill (manufactured by Shinko Pantech Co., Ltd.), and the average particle diameter of L-ascorbic acid was determined to be 0.4 μm by laser diffraction particle size distribution measurement. The resulting W / O dispersion composition was obtained.

【0018】試験例1 中鎖脂肪酸トリグリセリド50重量部(融点−11℃,
太陽化学株式会社製)、ポリグリセリン縮合リシノレイ
ン酸エステル10重量部(サンソフト818H;HLB
1,太陽化学株式会社製)を混合し、10%L−アスコ
ルビン酸水溶液40重量部(pH2.0)を加えながら
ホモミキサー(特殊機化工業株式会社製)にて高速攪拌
を行い、レーザー回折型粒度分布測定により内部水相の
平均粒子径が0.4μmとなったW/O乳化液を調製し
た。これを対照として実施例1のW/O分散組成物中に
おけるL−アスコルビン酸の酸化状態を比較した。
Test Example 1 50 parts by weight of medium chain fatty acid triglyceride (melting point −11 ° C.,
Taiyo Chemical Co., Ltd.), 10 parts by weight of polyglycerin condensed ricinoleate (Sunsoft 818H; HLB)
1, manufactured by Taiyo Kagaku Co., Ltd.) and stirred at high speed with a homomixer (manufactured by Tokushu Kika Kogyo Co., Ltd.) while adding 40 parts by weight (pH 2.0) of a 10% aqueous solution of L-ascorbic acid, followed by laser diffraction. A W / O emulsion having an average particle size of the internal aqueous phase of 0.4 μm as determined by a mold particle size distribution measurement was prepared. Using this as a control, the oxidation state of L-ascorbic acid in the W / O dispersion composition of Example 1 was compared.

【0019】両者各200gをそれぞれ耐圧ビンに封じ
て121℃、30分間の加熱殺菌を行い、放冷後に20
gを分取し、2%メタリン酸水溶液200mlとn−へ
キサン200mlを加えて室温下に振盪抽出を実施し、
得られた水層部分を回収して0.45μmのメンブレン
フィルターにて濾過して試験液とし、アミド結合型逆相
カラム(アミド80、東ソー株式会社製)を設置したH
PLCによりL−アスコルビン酸量を測定した。溶出溶
媒はアセトニトリル/2.5mMリン酸カリウム溶液
(50/50)を用い、検出は254nmの吸光度によ
り測定した。その後、両者を50℃で3ヶ月間保存し、
1ヶ月毎に上記と同様の測定を行うと共に乳化状態を観
察した。
200 g of each of the two was sealed in a pressure bottle and sterilized by heating at 121 ° C. for 30 minutes.
g, 200 ml of a 2% aqueous solution of metaphosphoric acid and 200 ml of n-hexane were added, and the mixture was shaken and extracted at room temperature.
The obtained aqueous layer was collected and filtered through a 0.45 μm membrane filter to obtain a test solution, and H was provided with an amide-bonded reverse-phase column (Amide 80, manufactured by Tosoh Corporation).
The amount of L-ascorbic acid was measured by PLC. The elution solvent used was an acetonitrile / 2.5 mM potassium phosphate solution (50/50), and the detection was measured by the absorbance at 254 nm. Then, both are stored at 50 ° C. for 3 months,
The same measurement as described above was performed every month, and the emulsified state was observed.

【0020】L−アスコルビン酸は水存在下で2位及び
3位のエノール基より水素原子を容易に失い、ケト型異
性体であるデヒドロアスコルビン酸となり、更に酸化が
進むと2,3−ジケトグロン酸をへてシュウ酸等に分解
する。これらの化合物中L−アスコルビン酸のみが25
4nmの波長に特異的な吸収を呈する性質があるため、
これを指標としてL−アスコルビン酸の残存率を求め
て、ビタミンCとしての安定性を比較した。
L-ascorbic acid easily loses a hydrogen atom from the enol groups at the 2- and 3-positions in the presence of water, and becomes a keto-type isomer, dehydroascorbic acid. To decompose into oxalic acid. Only L-ascorbic acid in these compounds is 25%
Because it has the property of exhibiting specific absorption at a wavelength of 4 nm,
Using this as an index, the residual ratio of L-ascorbic acid was determined, and the stability as vitamin C was compared.

【0021】その結果、表1に示すように実施例1のW
/O分散組成物においてはL−アスコルビン酸の減衰が
殆ど生じず、優れた安定化性を示した。
As a result, as shown in Table 1, W
In the / O dispersion composition, the attenuation of L-ascorbic acid hardly occurred, and excellent stability was exhibited.

【0022】[0022]

【表1】 [Table 1]

【0023】試験例2 菜種白絞油70重量部(融点12℃)、ポリグリセリン
縮合リシノレイン酸エステル10重量部(サンソフト8
18H;HLB1,太陽化学株式会社製)を混合し、2
%リボフラビン水溶液20重量部(武田薬品工業株式会
社製)を加えながらホモミキサー(特殊機化工業株式会
社製)にて高速攪拌を行い、レーザー回折型粒度分布測
定により内部水相の平均粒子径が0.35μmとなった
W/O乳化液を調製した。これを対照として実施例2の
W/O分散組成物を10人のパネラーにより官能試験を
実施してリボフラビンの特異な風味のマスキング性を比
較した。
Test Example 2 70 parts by weight of rapeseed white oil (melting point: 12 ° C.), 10 parts by weight of polyglycerin condensed ricinoleate (Sunsoft 8)
18H; HLB1, manufactured by Taiyo Chemical Co., Ltd.)
% Riboflavin aqueous solution (manufactured by Takeda Pharmaceutical Co., Ltd.) while adding 20 parts by weight of a riboflavin aqueous solution with high-speed stirring using a homomixer (manufactured by Tokushu Kika Kogyo Co., Ltd.). A W / O emulsion of 0.35 μm was prepared. Using this as a control, a sensory test was conducted on the W / O dispersion composition of Example 2 by 10 panelists to compare the unique flavor masking properties of riboflavin.

【0024】その結果、表2に示すように実施例2のW
/O分散組成物においてはリボフラビンの特異な風味を
殆ど感じさせない、優れた呈味性を示した。
As a result, as shown in Table 2, W of Example 2
The / O dispersion composition exhibited excellent taste with little or no unique flavor of riboflavin.

【0025】[0025]

【表2】 [Table 2]

【0026】試験例3 中鎖脂肪酸トリグリセリド50重量部(融点−11℃,
太陽化学株式会社製)、ポリグリセリン縮合リシノレイ
ン酸エステル10重量部(サンソフト818H;HLB
1,太陽化学株式会社製)を混合し、10%L−アスコ
ルビン酸水溶液40重量部(pH2.0)を加えながら
ホモミキサー(特殊機化工業株式会社製)にて高速攪拌
を行い、レーザー回折型粒度分布測定により内部水相の
平均粒子径が0.4μmとなったW/O乳化液を調製し
た。これをショ糖脂肪酸エステル5重量部(リョートー
シュガーエステルS−1670,三菱化学株式会社製)
を溶解させた水1000重量部中に加えて攪拌してW/
O/W乳化液を調製した。
Test Example 3 50 parts by weight of medium-chain fatty acid triglyceride (melting point −11 ° C.,
Taiyo Chemical Co., Ltd.), 10 parts by weight of polyglycerin condensed ricinoleate (Sunsoft 818H; HLB)
1, manufactured by Taiyo Kagaku Co., Ltd.) and stirred at high speed with a homomixer (manufactured by Tokushu Kika Kogyo Co., Ltd.) while adding 40 parts by weight (pH 2.0) of a 10% aqueous solution of L-ascorbic acid, followed by laser diffraction. A W / O emulsion having an average particle size of the internal aqueous phase of 0.4 μm as determined by a mold particle size distribution measurement was prepared. 5 parts by weight of sucrose fatty acid ester (Ryoto Sugar Ester S-1670, manufactured by Mitsubishi Chemical Corporation)
Was dissolved in 1000 parts by weight of water in which
An O / W emulsion was prepared.

【0027】同様に実施例3のW/O分散組成物もショ
糖脂肪酸エステル5重量部(リョートーシュガーエステ
ルS−1670,三菱化学株式会社製)を溶解させた水
1000重量部中に加えて攪拌してW/O/W乳化液を
調製し、両者各200gをそれぞれ耐圧ビンに封じて1
21℃、15分間の加熱殺菌を行い、放冷後に50gを
分取し、2%メタリン酸水溶液200mlとn−へキサ
ン200mlを加えて室温下に振盪抽出を実施し、得ら
れた水層部分を回収して0.45μmのメンブレンフィ
ルターにて濾過して試験液とし、アミド結合型逆相カラ
ム(アミド80、東ソー株式会社製)を設置したHPL
CによりL−アスコルビン酸量を測定した。溶出溶媒は
アセトニトリル/2.5mMリン酸カリウム溶液(50
/50)を用い、検出は254nmの吸光度により測定
した。その後、両者を40℃で3週間保存し、1週間毎
に上記と同様の測定を行うと共に乳化状態を観察した。
Similarly, the W / O dispersion composition of Example 3 was added to 1000 parts by weight of water in which 5 parts by weight of sucrose fatty acid ester (Ryoto Sugar Ester S-1670, manufactured by Mitsubishi Chemical Corporation) was dissolved. Stir to prepare a W / O / W emulsion, seal 200 g of each with a pressure bottle,
The solution was sterilized by heating at 21 ° C. for 15 minutes. After cooling, 50 g of the solution was collected, 200 ml of a 2% aqueous solution of metaphosphoric acid and 200 ml of n-hexane were added, and the mixture was shaken and extracted at room temperature. Was collected and filtered through a 0.45 μm membrane filter to obtain a test solution, and an HPL equipped with an amide-bonded reverse-phase column (Amide 80, manufactured by Tosoh Corporation) was used.
C was used to measure the amount of L-ascorbic acid. The elution solvent was acetonitrile / 2.5 mM potassium phosphate solution (50 mM).
/ 50), and the detection was measured by the absorbance at 254 nm. Thereafter, both were stored at 40 ° C. for 3 weeks, and the same measurement was carried out every week, and the emulsified state was observed.

【0028】その結果、表3に示すように実施例3のW
/O分散組成物は、W/O/W型の不安定な乳化条件下
においてもL−アスコルビン酸の減衰が殆ど生じず、優
れた安定化性を示した。
As a result, as shown in Table 3, W of Example 3
The / O dispersion composition showed excellent stabilization even with little attenuation of L-ascorbic acid even under unstable emulsification conditions of the W / O / W type.

【0029】[0029]

【表3】 [Table 3]

【0030】応用例1 実施例3のL−アスコルビン酸W/O分散組成物3重量
部を市販のプレーンヨーグルト100重量部に添加して
攪拌混合し、1200mg/gのビタミンC強化ヨーグ
ルトを調製した。対照としてL−アスコルビン酸1.2
重量部を同様のプレーンヨーグルト100重量部に添加
溶解したヨーグルトを調製して、両者における風味、製
品形態及びL−アスコルビン酸の残存率について比較し
たところ、対照品においてはL−アスコルビン酸の酸味
が著しく顕著であり、pHの低下による乳蛋白質の溶解
が生じてヨーグルトの形態を逸脱した状態となったが、
実施例3のW/O分散組成物を添加したものでは、本来
の風味を殆ど損なう事はなかった。
Application Example 1 3 parts by weight of the L / ascorbic acid W / O dispersion composition of Example 3 was added to 100 parts by weight of a commercially available plain yogurt and mixed by stirring to prepare 1200 mg / g vitamin C-enriched yogurt. . L-ascorbic acid 1.2 as a control
A part of the yogurt was prepared by adding 100 parts by weight of the same plain yogurt and dissolved, and the flavor, the product form and the residual ratio of L-ascorbic acid were compared. It was remarkably remarkable, and the milk protein was dissolved by the decrease in pH, and the state became out of the form of yogurt,
In the case where the W / O dispersion composition of Example 3 was added, the original flavor was hardly impaired.

【0031】また、両者のL−アスコルビン酸残存率を
試験例3の測定法に準拠して分析したところ、対照品で
は残存率45.0%であったに対し、実施例3のW/O
分散組成物を添加したものでの残存率は94.3%であ
り、水系の酸性食品中における本発明の効果を十分に確
認できた。
When the residual ratio of L-ascorbic acid was analyzed in accordance with the measuring method of Test Example 3, the residual ratio of the control product was 45.0%, whereas the residual ratio of W / O of Example 3 was 45.0%.
The residual ratio in the case where the dispersion composition was added was 94.3%, and the effect of the present invention in an aqueous acidic food was sufficiently confirmed.

【0032】応用例2 実施例1のL−アスコルビン酸W/O分散組成物3重量
部を市販のケーキプレミックス100重量部に添加して
攪拌混合し、160℃、30分間焼成してパウンドケー
キを調製した。対照としてL−アスコルビン酸1.2重
量部を同様のケーキプレミックス100重量部に添加溶
解したパウンドケーキを調製して、両者における風味、
製品形態及びL−アスコルビン酸の残存率について比較
したところ、対照品においてはL−アスコルビン酸の酸
味が著しく顕著であり、ケーキの起泡性が低下して嵩の
低い状態となったが、実施例3のW/O分散組成物を添
加したものでは、本来の風味及び起泡性を殆ど損なう事
はなかった。
Application Example 2 3 parts by weight of the L / ascorbic acid W / O dispersion composition of Example 1 was added to 100 parts by weight of a commercially available cake premix, mixed by stirring, and baked at 160 ° C. for 30 minutes to form a pound cake. Was prepared. As a control, 1.2 parts by weight of L-ascorbic acid was added to and dissolved in 100 parts by weight of the same cake premix to prepare a pound cake.
When the product form and the residual ratio of L-ascorbic acid were compared, the acidity of L-ascorbic acid was remarkably remarkable in the control product, and the foaming property of the cake was reduced to a low bulk state. In the case where the W / O dispersion composition of Example 3 was added, the original flavor and foamability were hardly impaired.

【0033】また、両者のL−アスコルビン酸残存率を
試験例3の測定法に準拠して分析したところ、対照品で
は残存率30.0%であったに対し、実施例3のW/O
分散組成物を添加したものでの残存率は87.3%であ
り、加熱工程下での本発明の効果を十分に確認できた。
When the residual ratio of L-ascorbic acid was analyzed in accordance with the measuring method of Test Example 3, the residual ratio of the control product was 30.0%, whereas the W / O ratio of Example 3 was
The residual ratio in the case where the dispersion composition was added was 87.3%, and the effect of the present invention in the heating step could be sufficiently confirmed.

【0034】[0034]

【発明の効果】ビタミン類の効果的な供給が健康維持に
必要である事は言うまでもないが、水溶性ビタミンにお
いては自身の分解性及び特異な風味を有する事から従来
糖衣錠、打錠剤及びドリンク剤等の医薬品的な供給形態
が一般化されていた。最近になり清涼飲料水及びビスケ
ット等の食品中に配合される形態が多く見受けられる
が、殺菌工程や焼成工程等の厳しい熱履歴を必須とする
食品中においてはビタミン本来の生理活性が著しく損な
われている現状にある。本発明の水溶性ビタミン組成物
を水溶液中、好ましくは乳飲料、清涼飲料、果汁飲料、
茶飲料、コーヒー飲料等の嗜好飲料、ヨーグルト、アイ
スクリーム、ホィップクリーム等の乳加工製品、プリ
ン、ゼリー等のデザート類等の水系食品、または化粧乳
液やローション等の水系化粧品中に分散させる時、乳化
転相により内包する水溶性ビタミンが溶出する事なく、
安定なW/O/W乳化系を構成する事を特徴とする。こ
こで言うW/O/W乳化系は、水中に分散する中性脂質
の油滴の中に水溶性ビタミンの超微粒子結晶が安定分散
する2重乳化構造を示す。本発明は、我々人間に必須の
水溶性ビタミンを多様な食品加工に適応しうる形態を与
えるものであり、特定のビタミンに限定される事無く全
ての水溶性ビタミンに応用されるものである。
It is needless to say that effective supply of vitamins is necessary for maintaining health. However, since water-soluble vitamins have their own degradability and peculiar flavor, they are conventionally used in sugar-coated tablets, tablet tablets and drinks. Pharmaceutical supply forms such as have been generalized. In recent years, many types of foods such as soft drinks and biscuits have been found in foods.However, in foods that require a severe heat history such as sterilization and baking, the natural physiological activity of vitamins is significantly impaired. It is in the present situation. In the aqueous solution of the water-soluble vitamin composition of the present invention, preferably milk drink, soft drink, fruit juice drink,
Emulsification when dispersed in taste drinks such as tea drinks and coffee drinks, dairy products such as yogurt, ice cream and whipped cream, water-based foods such as desserts such as pudding and jelly, or water-based cosmetics such as cosmetic milky lotions and lotions Water-soluble vitamins included by phase inversion do not elute,
It is characterized by constituting a stable W / O / W emulsion system. The W / O / W emulsification system referred to herein has a double emulsification structure in which ultrafine crystal particles of a water-soluble vitamin are stably dispersed in oil droplets of a neutral lipid dispersed in water. The present invention provides water-soluble vitamins essential to human beings in a form that can be adapted to various food processing, and is applicable to all water-soluble vitamins without being limited to specific vitamins.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61K 47/14 A61K 47/14 J 47/44 47/44 J ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 7 Identification FI FI Theme Court ゛ (Reference) A61K 47/14 A61K 47/14 J 47/44 47/44 J

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】 水溶性ビタミン、グリセリン脂肪酸エス
テル及び中性脂質を含有するビタミン組成物。
1. A vitamin composition comprising a water-soluble vitamin, a glycerin fatty acid ester and a neutral lipid.
【請求項2】 水溶性ビタミンが平均粒径1μm以下の
固体である事を特徴とする請求項1記載のビタミン組成
物。
2. The vitamin composition according to claim 1, wherein the water-soluble vitamin is a solid having an average particle size of 1 μm or less.
【請求項3】 グリセリン脂肪酸エステルがHLB4以
下である事を特徴とする請求項2または3記載のビタミ
ン組成物。
3. The vitamin composition according to claim 2, wherein the glycerin fatty acid ester has an HLB of 4 or less.
【請求項4】 中性脂質の融点が45℃以下である事を
特徴とする請求項1〜3何れか1項に記載のビタミン組
成物。
4. The vitamin composition according to claim 1, wherein the melting point of the neutral lipid is 45 ° C. or lower.
JP22534398A 1998-07-24 1998-07-24 Water-soluble vitamin composition Expired - Lifetime JP4173927B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP22534398A JP4173927B2 (en) 1998-07-24 1998-07-24 Water-soluble vitamin composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP22534398A JP4173927B2 (en) 1998-07-24 1998-07-24 Water-soluble vitamin composition

Publications (2)

Publication Number Publication Date
JP2000044474A true JP2000044474A (en) 2000-02-15
JP4173927B2 JP4173927B2 (en) 2008-10-29

Family

ID=16827866

Family Applications (1)

Application Number Title Priority Date Filing Date
JP22534398A Expired - Lifetime JP4173927B2 (en) 1998-07-24 1998-07-24 Water-soluble vitamin composition

Country Status (1)

Country Link
JP (1) JP4173927B2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001231470A (en) * 2000-02-24 2001-08-28 Taiyo Kagaku Co Ltd Gel composition
WO2003000248A1 (en) * 2001-06-22 2003-01-03 Taisho Pharmaceutical Co., Ltd. Liquid composition
JP2005097291A (en) * 2003-09-01 2005-04-14 Taisho Pharmaceut Co Ltd W/o/w type double emulsion

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001231470A (en) * 2000-02-24 2001-08-28 Taiyo Kagaku Co Ltd Gel composition
WO2003000248A1 (en) * 2001-06-22 2003-01-03 Taisho Pharmaceutical Co., Ltd. Liquid composition
JP2005097291A (en) * 2003-09-01 2005-04-14 Taisho Pharmaceut Co Ltd W/o/w type double emulsion

Also Published As

Publication number Publication date
JP4173927B2 (en) 2008-10-29

Similar Documents

Publication Publication Date Title
Zhu et al. Review on the stability mechanism and application of water‐in‐oil emulsions encapsulating various additives
Burgos-Díaz et al. Multilayer emulsions stabilized by vegetable proteins and polysaccharides
Zarrabi et al. Nanoliposomes and tocosomes as multifunctional nanocarriers for the encapsulation of nutraceutical and dietary molecules
JP3414530B2 (en) Stable emulsified composition and food containing it
EP0659347B1 (en) Stable emulsified compositions and foods containing the same
US6048557A (en) PUFA coated solid carrier particles for foodstuff
RU2592572C2 (en) Composition and method of increasing stability of additives to food products
US6428832B2 (en) Late addition of PUFA in infant formula preparation process
US20080311255A1 (en) Powder Compositions
JP4044354B2 (en) Composition having alcohol resistance, acid resistance and salt resistance and uses
RU2501328C2 (en) Phytosterols dispersion
JP3941073B2 (en) Oil and fat composition and food containing the same
JP2009505809A (en) Emulsifier system, its emulsion and its use
JP2008245588A (en) Emulsifier composition and oil-in-water emulsion
CN110809410A (en) Emulsions in food products
JP3720375B2 (en) Polyunsaturated fatty acid coated solid carrier particles for food
JP2003113393A (en) Ceramide dispersion, method for producing the same, and application of the same
JP2001231470A (en) Gel composition
CA2331661A1 (en) Use of &#39;nanofood&#39; in foodstuff final products for humans and animals
JP4060587B2 (en) Capsaicinoid-like substance-containing preparation
Zuidam An industry perspective on the advantages and disadvantages of iron micronutrient delivery systems
EP2260716B1 (en) Late addition of PUFA in infant formula preparation process
JP4173927B2 (en) Water-soluble vitamin composition
JP2004261005A (en) Ubidecarenone preparation
JP2005047851A (en) Ubidecarenone-containing composition

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050719

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070925

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20071126

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20080212

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080414

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20080617

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20080729

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20080815

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110822

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110822

Year of fee payment: 3

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110822

Year of fee payment: 3

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120822

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130822

Year of fee payment: 5

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term